Literature DB >> 982547

Effects of suramin on ocular onchocerciasis.

J Anderson, H Fuglsang, T F de C Marshall.   

Abstract

39 patients (Group A) with ocular onchocerciasis in the Sudan-savanna of north Cameroon were given 4-6 g of suramin and followed in detail over 1-2 years. 39 other patients (Group B) received suramin followed 2 weeks later by a 6-7 day course of diethylcarbamazine (DEC). A further 18 patients (Group C) received placebo injections and were followed in the same way by the same observers. Suramin caused serious general reactions among the 100 patients who started the course - 1 case of stomatitis, 1 exfoliative dermatitis, and several cases of severe prostration, among which 2 ended fatally. These reactions underline the urgency for further studies on the toxicity of suramin, which is without doubt an efficient macro- and micro-filaricidal drug. Changes which occurred in the ocular lesions are described in detail. There was an initial aggravation of punctate and sclerosing keratitis, and sometimes a serious aggravation or development of anterior uveitis, corresponding to the peak microfilaricidal effect of the drug. The possibility of a simultaneous adverse effect on the optic disc is discussed. Despite these reactions, which might have been avoided by prior elimination of microfilariae by DEC, the eyes were in general quieter at 3 months and thereafter than before treatment. However, no posterior segment lesion improved after suramin, and the majority remained unchanged. The findings at the end of the trial were as follows: No. of lesions (see article).

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 982547

Source DB:  PubMed          Journal:  Tropenmed Parasitol        ISSN: 0303-4208


  19 in total

1.  Decrease in adverse reactions after repeated ivermectin treatment in onchocerciasis.

Authors:  A Van der Lelij; A Rothova; N Klaassen-Broekema; W R Wilson; R F Barbe; J S Stilma
Journal:  Doc Ophthalmol       Date:  1990-10       Impact factor: 2.379

2.  Effect of single-dose ivermectin therapy on human Onchocerca volvulus infection with onchocercal ocular involvement.

Authors:  H S Newland; A T White; B M Greene; S A D'Anna; E Keyvan-Larijani; M A Aziz; P N Williams; H R Taylor
Journal:  Br J Ophthalmol       Date:  1988-08       Impact factor: 4.638

3.  The risk of optic atrophy following suramin treatment of ocular onchocerciasis.

Authors:  B Thylefors; A Rolland
Journal:  Bull World Health Organ       Date:  1979       Impact factor: 9.408

4.  Ocular onchocerciasis.

Authors:  B Thylefors
Journal:  Bull World Health Organ       Date:  1978       Impact factor: 9.408

5.  Recent developments in the treatment of onchocerciasis.

Authors:  H R Taylor
Journal:  Bull World Health Organ       Date:  1984       Impact factor: 9.408

6.  Further studies on the treatment of ocular onchocerciasis with diethylcarbamazine and suramin.

Authors:  J Anderson; H Fuglsang
Journal:  Br J Ophthalmol       Date:  1978-07       Impact factor: 4.638

7.  Aggregation of equine platelets by Onchocerca cervicalis collagen.

Authors:  L A McConnell; R W Leid
Journal:  Am J Pathol       Date:  1983-03       Impact factor: 4.307

8.  Modulation of equine platelet function by diethylcarbamazine (DEC).

Authors:  K A Kowalski; L A McConnell; D A Sadoff; R W Leid
Journal:  Am J Pathol       Date:  1983-10       Impact factor: 4.307

9.  Ocular findings in a double-blind study of ivermectin versus diethylcarbamazine versus placebo in the treatment of onchocerciasis.

Authors:  K Y Dadzie; A C Bird; K Awadzi; H Schulz-Key; H M Gilles; M A Aziz
Journal:  Br J Ophthalmol       Date:  1987-02       Impact factor: 4.638

10.  East African trypanosomiasis in a pregnant traveler.

Authors:  Behzad Nadjm; Chris Van Tulleken; Douglas Macdonald; Peter L Chiodini
Journal:  Emerg Infect Dis       Date:  2009-11       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.